Biotechnology
The Biotechnology industry has a total of 677 stocks, with a combined market cap of $1,450.02 billion and total revenue of $121.81 billion.
Market Cap
1,450.02B
Revenue
121.81B
Profits
-33.53B
PE Ratio
n/a
Profit Margin
-27.53%
Dividend Yield
0.09%
677 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 570.64B | 1.06% | 2,556,191 | 35.35B |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 112.99B | 2.19% | 479,654 | 10.19B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 106.09B | -0.57% | 325,912 | 13.10B |
| 4 | MRNA | Moderna, Inc. | 49.20B | - | 1,662,006 | 5.15B |
| 5 | BNTX | BioNTech SE | 22.00B | 0.30% | 303,052 | 2.97B |
| 6 | ARGX | argenx SE | 21.25B | 5.26% | 246,472 | 39.48M |
| 7 | GMAB | Genmab A/S | 19.74B | 2.52% | 385,025 | 2.57B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 18.72B | 0.07% | 286,992 | 2.00B |
| 9 | BGNE | BeiGene, Ltd. | 17.94B | 2.61% | 67,548 | 2.76B |
| 10 | BMRN | BioMarin Pharmaceutical Inc. | 15.31B | 1.22% | 981,509 | 2.47B |
| 11 | TECH | Bio-Techne Corporation | 13.14B | -0.89% | 516,763 | 1.15B |
| 12 | INCY | Incyte Corporation | 12.85B | 0.30% | 1,854,611 | 3.77B |
| 13 | RPRX | Royalty Pharma plc | 12.74B | 0.61% | 1,007,821 | 2.24B |
| 14 | SRPT | Sarepta Therapeutics, Inc. | 12.63B | 0.72% | 369,240 | 1.40B |
| 15 | UTHR | United Therapeutics Corporation | 12.16B | 1.58% | 166,120 | 2.50B |
| 16 | ROIV | Roivant Sciences Ltd. | 9.31B | 1.94% | 1,382,826 | 123.24M |
| 17 | VKTX | Viking Therapeutics, Inc. | 8.49B | 6.21% | 2,727,120 | - |
| 18 | LEGN | Legend Biotech Corporation | 8.29B | 2.60% | 579,466 | 342.80M |
| 19 | PCVX | Vaxcyte, Inc. | 7.72B | 5.12% | 312,935 | - |
| 20 | CERE | Cerevel Therapeutics Holdings, Inc. | 7.67B | -0.34% | 531,291 | - |
| 21 | ASND | Ascendis Pharma A/S | 7.09B | 0.37% | 605,094 | 357.63M |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 6.91B | -2.01% | 426,372 | 3.84B |
| 23 | BPMC | Blueprint Medicines Corporation | 6.69B | 1.32% | 278,887 | 282.21M |
| 24 | RVMD | Revolution Medicines, Inc. | 6.53B | 6.05% | 728,407 | 4.57M |
| 25 | CYTK | Cytokinetics, Incorporated | 6.31B | 1.32% | 606,501 | 3.75M |
| 26 | EXEL | Exelixis, Inc. | 6.18B | 1.05% | 744,425 | 1.85B |
| 27 | HALO | Halozyme Therapeutics, Inc. | 5.85B | 4.83% | 661,025 | 862.99M |
| 28 | IONS | Ionis Pharmaceuticals, Inc. | 5.72B | 2.42% | 434,429 | 776.62M |
| 29 | BBIO | BridgeBio Pharma, Inc. | 5.56B | 2.42% | 567,921 | 218.60M |
| 30 | IBRX | ImmunityBio, Inc. | 5.49B | -3.39% | 2,764,467 | 302.00K |
| 31 | APLS | Apellis Pharmaceuticals, Inc. | 5.10B | 2.00% | 602,680 | 524.07M |
| 32 | CRSP | CRISPR Therapeutics AG | 4.84B | 2.20% | 1,003,850 | 271.71M |
| 33 | KRYS | Krystal Biotech, Inc. | 4.72B | 3.64% | 161,904 | 95.95M |
| 34 | NUVL | Nuvalent, Inc. | 4.62B | 5.27% | 212,108 | - |
| 35 | MDGL | Madrigal Pharmaceuticals, Inc. | 4.50B | 0.30% | 270,971 | - |
| 36 | IMVT | Immunovant, Inc. | 4.48B | 1.02% | 464,182 | - |
| 37 | ALPN | Alpine Immune Sciences, Inc. | 4.46B | 0.01% | 1,041,832 | 56.52M |
| 38 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.02B | 3.07% | 507,737 | 1.97M |
| 39 | INSM | Insmed Incorporated | 3.73B | -1.30% | 1,060,934 | 315.49M |
| 40 | AXSM | Axsome Therapeutics, Inc. | 3.65B | -0.78% | 166,563 | 251.02M |
| 41 | RARE | Ultragenyx Pharmaceutical Inc. | 3.44B | 1.15% | 457,006 | 442.59M |
| 42 | SWTX | SpringWorks Therapeutics, Inc. | 3.33B | 4.49% | 262,524 | 26.45M |
| 43 | BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.30B | 1.66% | 606,867 | - |
| 44 | IDYA | IDEAYA Biosciences, Inc. | 3.22B | 1.91% | 415,357 | 15.50M |
| 45 | SMMT | Summit Therapeutics Inc. | 3.12B | -5.23% | 1,124,447 | - |
| 46 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.10B | 9.43% | 596,667 | 35.47M |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 3.07B | 0.39% | 132,999 | - |
| 48 | IOVA | Iovance Biotherapeutics, Inc. | 3.04B | 1.26% | 3,613,615 | 1.90M |
| 49 | APGE | Apogee Therapeutics, Inc. | 3.02B | -0.91% | 431,680 | - |
| 50 | DNLI | Denali Therapeutics Inc. | 2.91B | 3.24% | 456,341 | 295.39M |
| 51 | CORT | Corcept Therapeutics Incorporated | 2.90B | 0.58% | 322,667 | 523.53M |
| 52 | FOLD | Amicus Therapeutics, Inc. | 2.83B | 2.63% | 1,274,808 | 423.49M |
| 53 | RNA | Avidity Biosciences, Inc. | 2.83B | 2.32% | 922,705 | 10.87M |
| 54 | ACLX | Arcellx, Inc. | 2.80B | 3.81% | 416,115 | 131.66M |
| 55 | IMCR | Immunocore Holdings plc | 2.78B | -0.13% | 566,395 | 264.25M |
| 56 | TGTX | TG Therapeutics, Inc. | 2.77B | -0.17% | 2,025,298 | 289.33M |
| 57 | MOR | MorphoSys AG | 2.77B | 0.03% | 48,153 | 264.75M |
| 58 | CLDX | Celldex Therapeutics, Inc. | 2.66B | 2.06% | 302,040 | 6.07M |
| 59 | MRUS | Merus N.V. | 2.65B | 0.86% | 371,890 | 38.34M |
| 60 | FTRE | Fortrea Holdings Inc. | 2.59B | 0.49% | 607,397 | 3.11B |
| 61 | MLTX | MoonLake Immunotherapeutics | 2.58B | 0.60% | 98,234 | - |
| 62 | PTCT | PTC Therapeutics, Inc. | 2.58B | 7.86% | 314,972 | 927.56M |
| 63 | NTLA | Intellia Therapeutics, Inc. | 2.53B | 2.02% | 600,121 | 52.60M |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 2.49B | 1.48% | 1,013,565 | 813.81M |
| 65 | JANX | Janux Therapeutics, Inc. | 2.49B | -0.13% | 656,004 | 7.29M |
| 66 | VCEL | Vericel Corporation | 2.43B | 2.99% | 155,883 | 207.78M |
| 67 | RYTM | Rhythm Pharmaceuticals, Inc. | 2.41B | -2.07% | 161,303 | 91.93M |
| 68 | DYN | Dyne Therapeutics, Inc. | 2.40B | 5.10% | 654,195 | - |
| 69 | RXRX | Recursion Pharmaceuticals, Inc. | 2.32B | 0.60% | 5,190,823 | 46.24M |
| 70 | VERA | Vera Therapeutics, Inc. | 2.30B | 2.70% | 213,399 | - |
| 71 | ARVN | Arvinas, Inc. | 2.26B | 5.36% | 387,635 | 71.30M |
| 72 | GERN | Geron Corporation | 2.23B | 2.17% | 4,028,709 | 520.00K |
| 73 | KYMR | Kymera Therapeutics, Inc. | 2.19B | 1.62% | 283,538 | 79.41M |
| 74 | RCKT | Rocket Pharmaceuticals, Inc. | 2.16B | 1.67% | 152,197 | - |
| 75 | ADMA | ADMA Biologics, Inc. | 2.12B | -0.27% | 1,654,956 | 283.18M |
| 76 | ZLAB | Zai Lab Limited | 2.12B | -0.56% | 222,690 | 291.07M |
| 77 | SANA | Sana Biotechnology, Inc. | 2.03B | 6.63% | 976,126 | - |
| 78 | BEAM | Beam Therapeutics Inc. | 2.01B | 2.52% | 447,164 | 360.91M |
| 79 | AGIO | Agios Pharmaceuticals, Inc. | 1.99B | 2.43% | 227,131 | 29.40M |
| 80 | CPRX | Catalyst Pharmaceuticals, Inc. | 1.98B | 1.64% | 623,954 | 411.35M |
| 81 | KROS | Keros Therapeutics, Inc. | 1.98B | 3.79% | 72,439 | 234.00K |
| 82 | GLPG | Galapagos NV | 1.92B | 1.85% | 41,336 | - |
| 83 | SNDX | Syndax Pharmaceuticals, Inc. | 1.87B | 1.57% | 284,171 | - |
| 84 | PTGX | Protagonist Therapeutics, Inc. | 1.86B | 7.21% | 346,859 | 314.95M |
| 85 | CGON | CG Oncology, Inc. | 1.85B | 1.72% | 615,550 | 539.00K |
| 86 | ARDX | Ardelyx, Inc. | 1.84B | 1.16% | 1,270,058 | 159.11M |
| 87 | FUSN | Fusion Pharmaceuticals Inc. | 1.83B | 0.47% | 160,091 | 2.04M |
| 88 | INBX | Inhibrx, Inc. | 1.79B | 0.03% | 1,621,684 | 1.78M |
| 89 | NAMS | NewAmsterdam Pharma Company N.V. | 1.78B | -3.80% | 177,690 | - |
| 90 | NVAX | Novavax, Inc. | 1.76B | -6.60% | 20,290,285 | 996.61M |
| 91 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.76B | -6.33% | 43,402,892 | 208.70M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 1.68B | -0.59% | 127,430 | 617.51M |
| 93 | GPCR | Structure Therapeutics Inc. | 1.68B | 1.37% | 269,396 | - |
| 94 | EWTX | Edgewise Therapeutics, Inc. | 1.66B | 1.66% | 619,116 | - |
| 95 | KURA | Kura Oncology, Inc. | 1.65B | 3.59% | 328,430 | - |
| 96 | SLNO | Soleno Therapeutics, Inc. | 1.64B | 3.59% | 80,119 | - |
| 97 | RCUS | Arcus Biosciences, Inc. | 1.59B | 1.52% | 380,951 | 237.00M |
| 98 | LGND | Ligand Pharmaceuticals Incorporated | 1.55B | 1.31% | 49,525 | 118.31M |
| 99 | NMRA | Neumora Therapeutics, Inc. | 1.53B | 0.42% | 454,407 | - |
| 100 | SYRE | Spyre Therapeutics, Inc. | 1.51B | -4.68% | 222,616 | 688.00K |
| 101 | MORF | Morphic Holding, Inc. | 1.50B | 5.61% | 161,733 | - |
| 102 | TARS | Tarsus Pharmaceuticals, Inc. | 1.47B | 2.49% | 216,587 | 42.56M |
| 103 | DAWN | Day One Biopharmaceuticals, Inc. | 1.46B | 0.48% | 244,337 | - |
| 104 | AKRO | Akero Therapeutics, Inc. | 1.43B | 2.17% | 210,386 | - |
| 105 | KNSA | Kiniksa Pharmaceuticals, Ltd. | 1.43B | 3.39% | 115,937 | 301.77M |
| 106 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.43B | 0.42% | 574,681 | 274.10M |
| 107 | VIR | Vir Biotechnology, Inc. | 1.37B | -0.35% | 346,961 | 79.60M |
| 108 | GYRE | Gyre Therapeutics, Inc. | 1.35B | -0.38% | 37,379 | 140.62M |
| 109 | XNCR | Xencor, Inc. | 1.33B | 6.14% | 286,084 | 162.18M |
| 110 | FDMT | 4D Molecular Therapeutics, Inc. | 1.33B | -0.27% | 218,670 | 20.45M |
| 111 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.32B | 19.22% | 7,673,624 | 355.40M |
| 112 | BLTE | Belite Bio, Inc | 1.26B | 0.23% | 26,790 | - |
| 113 | MNKD | MannKind Corporation | 1.22B | -0.67% | 1,139,854 | 224.60M |
| 114 | PRTA | Prothena Corporation plc | 1.19B | 7.35% | 196,970 | 89.25M |
| 115 | CGEM | Cullinan Oncology, Inc. | 1.19B | 4.42% | 313,045 | - |
| 116 | MDXG | MiMedx Group, Inc. | 1.18B | 1.65% | 325,745 | 334.51M |
| 117 | MIRM | Mirum Pharmaceuticals, Inc. | 1.17B | -0.16% | 151,902 | 224.00M |
| 118 | PHVS | Pharvaris N.V. | 1.16B | 3.10% | 41,503 | - |
| 119 | SRRK | Scholar Rock Holding Corporation | 1.14B | 1.75% | 597,343 | - |
| 120 | IMTX | Immatics N.V. | 1.14B | -4.22% | 386,807 | 80.95M |
| 121 | VRNA | Verona Pharma plc | 1.13B | 0.94% | 176,692 | - |
| 122 | SAVA | Cassava Sciences, Inc. | 1.13B | 0.94% | 606,459 | - |
| 123 | ELVN | Enliven Therapeutics, Inc. | 1.12B | 0.34% | 290,927 | - |
| 124 | ABCL | AbCellera Biologics Inc. | 1.11B | -1.70% | 500,949 | 35.79M |
| 125 | ARQT | Arcutis Biotherapeutics, Inc. | 1.07B | 13.84% | 10,597,336 | 106.39M |
| 126 | SLN | Silence Therapeutics plc | 1.05B | 6.39% | 34,438 | 32.12M |
| 127 | OCUL | Ocular Therapeutix, Inc. | 997.49M | 6.53% | 2,424,036 | 59.84M |
| 128 | INVA | Innoviva, Inc. | 992.87M | -1.30% | 504,396 | 311.59M |
| 129 | TYRA | Tyra Biosciences, Inc. | 969.20M | -0.73% | 65,047 | - |
| 130 | NRIX | Nurix Therapeutics, Inc. | 963.02M | 8.60% | 585,201 | 80.89M |
| 131 | PLRX | Pliant Therapeutics, Inc. | 959.18M | 12.66% | 915,407 | 248.00K |
| 132 | BCYC | Bicycle Therapeutics plc | 938.34M | 1.33% | 140,586 | 41.61M |
| 133 | LQDA | Liquidia Corporation | 928.05M | 1.51% | 301,802 | 15.97M |
| 134 | ETNB | 89bio, Inc. | 923.83M | 3.41% | 254,056 | - |
| 135 | VRDN | Viridian Therapeutics, Inc. | 919.68M | -1.84% | 261,402 | 288.00K |
| 136 | RLAY | Relay Therapeutics, Inc. | 907.96M | 7.70% | 1,627,477 | 35.33M |
| 137 | PROK | ProKidney Corp. | 896.37M | -6.19% | 915,331 | - |
| 138 | IMNM | Immunome, Inc. | 893.16M | 1.22% | 644,019 | 12.68M |
| 139 | ABVX | Abivax SA | 887.45M | 1.44% | 154,462 | 5.13M |
| 140 | SPRY | ARS Pharmaceuticals, Inc. | 870.11M | - | 156,692 | 10.00K |
| 141 | CNTA | Centessa Pharmaceuticals plc | 864.28M | -3.21% | 115,108 | 6.85M |
| 142 | ZNTL | Zentalis Pharmaceuticals, Inc. | 854.29M | 3.00% | 267,526 | 40.56M |
| 143 | TNGX | Tango Therapeutics, Inc. | 837.67M | 2.89% | 137,232 | 37.23M |
| 144 | CRGX | CARGO Therapeutics, Inc. | 826.94M | 6.60% | 86,155 | - |
| 145 | DNTH | Dianthus Therapeutics, Inc. | 826.78M | 0.75% | 67,706 | 2.26M |
| 146 | MESO | Mesoblast Limited | 821.69M | 0.28% | 60,535 | 7.25M |
| 147 | PRME | Prime Medicine, Inc. | 821.01M | 2.55% | 333,393 | 591.00K |
| 148 | LBPH | Longboard Pharmaceuticals, Inc. | 818.04M | 3.73% | 94,073 | - |
| 149 | IRON | Disc Medicine, Inc. | 797.89M | 1.51% | 98,850 | - |
| 150 | RGNX | REGENXBIO Inc. | 797.45M | 1.90% | 172,905 | 86.73M |
| 151 | HUMA | Humacyte, Inc. | 794.29M | 3.89% | 3,117,083 | - |
| 152 | ALXO | ALX Oncology Holdings Inc. | 782.73M | 2.18% | 100,787 | - |
| 153 | ARCT | Arcturus Therapeutics Holdings Inc. | 780.75M | -2.61% | 119,951 | 124.53M |
| 154 | AUPH | Aurinia Pharmaceuticals Inc. | 778.02M | 4.52% | 993,851 | 191.41M |
| 155 | PRTC | PureTech Health plc | 770.95M | 1.79% | 1,587 | 3.33M |
| 156 | PRAX | Praxis Precision Medicines, Inc. | 765.23M | -2.57% | 512,135 | 2.20M |
| 157 | NUVB | Nuvation Bio Inc. | 739.18M | 2.73% | 1,796,043 | - |
| 158 | STOK | Stoke Therapeutics, Inc. | 738.20M | 10.86% | 704,952 | 7.85M |
| 159 | COGT | Cogent Biosciences, Inc. | 732.88M | 4.29% | 232,417 | - |
| 160 | HLVX | HilleVax, Inc. | 727.42M | 11.23% | 441,109 | - |
| 161 | WVE | Wave Life Sciences Ltd. | 721.29M | 0.86% | 258,694 | 112.91M |
| 162 | SAGE | Sage Therapeutics, Inc. | 718.57M | -0.50% | 370,208 | 91.06M |
| 163 | CVAC | CureVac N.V. | 717.55M | 3.39% | 312,025 | 59.73M |
| 164 | ANAB | AnaptysBio, Inc. | 701.61M | 1.56% | 75,758 | 22.96M |
| 165 | KYTX | Kyverna Therapeutics, Inc. | 695.88M | 4.39% | 277,412 | - |
| 166 | AUTL | Autolus Therapeutics plc | 688.57M | 0.64% | 686,028 | 1.70M |
| 167 | SVRA | Savara Inc. | 678.51M | 2.08% | 281,309 | - |
| 168 | GHRS | GH Research PLC | 670.12M | -1.08% | 12,209 | - |
| 169 | EYPT | EyePoint Pharmaceuticals, Inc. | 667.46M | 3.01% | 629,583 | 50.02M |
| 170 | LYEL | Lyell Immunopharma, Inc. | 656.47M | 1.38% | 302,552 | 68.00K |
| 171 | AVBP | ArriVent BioPharma, Inc. | 646.43M | 4.09% | 26,328 | - |
| 172 | PHAR | Pharming Group N.V. | 645.49M | 2.19% | 1,732 | 280.83M |
| 173 | MLYS | Mineralys Therapeutics, Inc. | 641.96M | -1.30% | 29,364 | - |
| 174 | ITOS | iTeos Therapeutics, Inc. | 641.44M | 6.64% | 360,593 | - |
| 175 | ZYME | Zymeworks Inc. | 641.29M | 0.83% | 220,498 | 50.46M |
| 176 | EXAI | Exscientia plc | 632.28M | 0.80% | 445,593 | 25.42M |
| 177 | MNMD | Mind Medicine (MindMed) Inc. | 630.29M | 5.42% | 964,655 | - |
| 178 | ORIC | ORIC Pharmaceuticals, Inc. | 629.05M | 2.86% | 241,187 | - |
| 179 | PHAT | Phathom Pharmaceuticals, Inc. | 606.31M | -0.67% | 197,505 | 2.59M |
| 180 | VALN | Valneva SE | 604.97M | 8.74% | 40,019 | 166.26M |
| 181 | ENGN | enGene Holdings Inc. | 603.74M | -4.14% | 3,664 | - |
| 182 | ALT | Altimmune, Inc. | 601.11M | 8.44% | 2,246,634 | 410.00K |
| 183 | CALT | Calliditas Therapeutics AB (publ) | 594.06M | -1.64% | 1,282 | 119.73M |
| 184 | CABA | Cabaletta Bio, Inc. | 590.68M | 12.29% | 618,349 | - |
| 185 | ADPT | Adaptive Biotechnologies Corporation | 585.79M | 0.38% | 889,684 | 174.50M |
| 186 | AVTE | Aerovate Therapeutics, Inc. | 583.08M | 5.68% | 256,081 | - |
| 187 | CDMO | Avid Bioservices, Inc. | 582.74M | -0.22% | 686,159 | 136.74M |
| 188 | IGMS | IGM Biosciences, Inc. | 582.46M | 7.39% | 290,727 | 2.11M |
| 189 | TSHA | Taysha Gene Therapies, Inc. | 573.21M | 19.26% | 3,048,568 | 14.16M |
| 190 | OLMA | Olema Pharmaceuticals, Inc. | 554.30M | -2.65% | 1,124,567 | - |
| 191 | ABSI | Absci Corporation | 545.06M | -0.52% | 392,072 | 5.35M |
| 192 | ABUS | Arbutus Biopharma Corporation | 538.98M | -0.17% | 160,331 | 12.99M |
| 193 | ALEC | Alector, Inc. | 537.83M | 4.50% | 241,993 | 96.41M |
| 194 | OABI | OmniAb, Inc. | 533.38M | 0.78% | 126,792 | 21.05M |
| 195 | YMAB | Y-mAbs Therapeutics, Inc. | 532.73M | 2.62% | 144,158 | 84.50M |
| 196 | CELC | Celcuity Inc. | 526.84M | 2.46% | 59,230 | - |
| 197 | TVTX | Travere Therapeutics, Inc. | 525.29M | 2.91% | 494,087 | 183.23M |
| 198 | KALV | KalVista Pharmaceuticals, Inc. | 524.82M | -0.40% | 104,577 | - |
| 199 | THRD | Third Harmonic Bio, Inc. | 524.74M | -0.23% | 49,415 | - |
| 200 | ALLO | Allogene Therapeutics, Inc. | 523.27M | 3.55% | 2,128,454 | 65.00K |
| 201 | ATXS | Astria Therapeutics, Inc. | 521.67M | 0.11% | 374,966 | - |
| 202 | FULC | Fulcrum Therapeutics, Inc. | 518.98M | 5.56% | 614,907 | 2.51M |
| 203 | APLT | Applied Therapeutics, Inc. | 510.20M | -3.77% | 606,047 | -477.00K |
| 204 | OCGN | Ocugen, Inc. | 506.65M | 15.29% | 10,801,685 | 7.05M |
| 205 | LRMR | Larimar Therapeutics, Inc. | 504.02M | -0.13% | 76,151 | - |
| 206 | URGN | UroGen Pharma Ltd. | 494.98M | 5.63% | 413,527 | 84.30M |
| 207 | NKTX | Nkarta, Inc. | 494.68M | 7.02% | 371,693 | - |
| 208 | EDIT | Editas Medicine, Inc. | 492.16M | 5.46% | 1,568,948 | 69.41M |
| 209 | VERV | Verve Therapeutics, Inc. | 490.15M | 0.08% | 679,002 | 16.05M |
| 210 | TRDA | Entrada Therapeutics, Inc. | 489.17M | 2.54% | 23,333 | 162.87M |
| 211 | FATE | Fate Therapeutics, Inc. | 480.37M | 0.24% | 1,053,358 | 6.48M |
| 212 | TBPH | Theravance Biopharma, Inc. | 476.83M | 5.54% | 125,522 | 57.42M |
| 213 | BMEA | Biomea Fusion, Inc. | 475.55M | 6.71% | 578,113 | - |
| 214 | LXRX | Lexicon Pharmaceuticals, Inc. | 475.24M | 0.52% | 994,437 | 2.31M |
| 215 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 469.31M | 2.28% | 178,144 | - |
| 216 | SLRN | Acelyrin, Inc. | 465.28M | 1.16% | 229,347 | - |
| 217 | VYGR | Voyager Therapeutics, Inc. | 464.47M | 0.47% | 265,985 | 119.04M |
| 218 | CBUS | Cibus, Inc. | 462.49M | -1.47% | 23,058 | 2.32M |
| 219 | LXEO | Lexeo Therapeutics, Inc. | 461.27M | -0.21% | 48,978 | - |
| 220 | PEPG | PepGen Inc. | 449.58M | -0.79% | 24,019 | - |
| 221 | RNAC | Cartesian Therapeutics, Inc. | 447.22M | 5.60% | 92,200 | 25.91M |
| 222 | HRTX | Heron Therapeutics, Inc. | 445.18M | 5.34% | 1,306,887 | 132.10M |
| 223 | OCS | Oculis Holding AG | 441.63M | -0.90% | 1,383 | 995.46K |
| 224 | NGNE | Neurogene Inc. | 426.47M | 4.28% | 28,246 | - |
| 225 | MREO | Mereo BioPharma Group plc | 421.33M | 5.41% | 344,792 | 10.00M |
| 226 | CCCC | C4 Therapeutics, Inc. | 419.72M | 1.67% | 623,805 | 20.04M |
| 227 | TCRX | TScan Therapeutics, Inc. | 415.04M | 0.11% | 256,612 | 14.81M |
| 228 | REPL | Replimune Group, Inc. | 414.98M | 0.75% | 242,533 | - |
| 229 | KRRO | Korro Bio, Inc. | 412.56M | 3.54% | 16,146 | - |
| 230 | ANNX | Annexon, Inc. | 411.05M | -6.33% | 1,723,848 | - |
| 231 | LENZ | LENZ Therapeutics, Inc. | 406.35M | 0.70% | 59,736 | - |
| 232 | VRCA | Verrica Pharmaceuticals Inc. | 402.57M | - | 141,590 | 8.91M |
| 233 | ADCT | ADC Therapeutics SA | 396.93M | 1.98% | 272,274 | 68.62M |
| 234 | TRML | Tourmaline Bio, Inc. | 389.57M | 5.27% | 106,425 | - |
| 235 | AVXL | Anavex Life Sciences Corp. | 385.97M | 5.80% | 902,470 | - |
| 236 | CTNM | Contineum Therapeutics, Inc. | 385.50M | -0.96% | 10,644 | 50.00M |
| 237 | STTK | Shattuck Labs, Inc. | 381.83M | -4.66% | 363,038 | 2.72M |
| 238 | FBLG | FibroBiologics, Inc. | 379.54M | 2.65% | 41,008 | - |
| 239 | CADL | Candel Therapeutics, Inc. | 376.53M | 20.28% | 986,590 | - |
| 240 | SLDB | Solid Biosciences Inc. | 372.93M | -2.01% | 39,774 | - |
| 241 | ANRO | Alto Neuroscience, Inc. | 372.61M | -2.05% | 97,088 | - |
| 242 | TERN | Terns Pharmaceuticals, Inc. | 370.26M | -4.34% | 564,689 | - |
| 243 | AURA | Aura Biosciences, Inc. | 365.55M | -2.12% | 60,511 | - |
| 244 | NAUT | Nautilus Biotechnology, Inc. | 360.76M | 1.05% | 115,489 | - |
| 245 | PGEN | Precigen, Inc. | 355.94M | 3.65% | 480,425 | 5.44M |
| 246 | QTTB | Q32 Bio Inc. | 355.28M | 3.38% | 11,143 | 354.00K |
| 247 | MGTX | MeiraGTx Holdings plc | 354.65M | 5.35% | 75,631 | 697.00K |
| 248 | ACIU | AC Immune SA | 353.14M | -1.68% | 843,707 | 16.82M |
| 249 | NBTX | Nanobiotix S.A. | 352.86M | 2.74% | 488 | 40.23M |
| 250 | SKYE | Skye Bioscience, Inc. | 349.80M | 3.54% | 32,126 | - |
| 251 | TNYA | Tenaya Therapeutics, Inc. | 349.01M | 0.91% | 156,687 | - |
| 252 | RVNC | Revance Therapeutics, Inc. | 348.60M | -4.60% | 1,542,955 | 236.65M |
| 253 | GUTS | Fractyl Health, Inc. | 339.46M | 5.29% | 135,009 | 148.00K |
| 254 | ATAI | Atai Life Sciences N.V. | 338.26M | 6.02% | 1,233,553 | 314.00K |
| 255 | IMMP | Immutep Limited | 336.44M | -3.58% | 184,236 | 4.58M |
| 256 | VSTM | Verastem, Inc. | 334.55M | 0.27% | 109,779 | - |
| 257 | CRBU | Caribou Biosciences, Inc. | 333.72M | 1.37% | 1,801,985 | 33.40M |
| 258 | NKTR | Nektar Therapeutics | 332.36M | 2.26% | 896,325 | 90.17M |
| 259 | STRO | Sutro Biopharma, Inc. | 330.34M | -6.68% | 265,618 | 154.07M |
| 260 | ERAS | Erasca, Inc. | 330.25M | 2.69% | 249,318 | - |
| 261 | INO | Inovio Pharmaceuticals, Inc. | 329.53M | 11.30% | 502,625 | 717.07K |
| 262 | PSTX | Poseida Therapeutics, Inc. | 326.62M | 15.07% | 887,240 | 82.50M |
| 263 | JSPR | Jasper Therapeutics, Inc. | 324.49M | 2.61% | 60,888 | - |
| 264 | MRSN | Mersana Therapeutics, Inc. | 315.69M | -0.38% | 1,021,151 | 38.30M |
| 265 | BDTX | Black Diamond Therapeutics, Inc. | 314.45M | -2.79% | 1,591,444 | - |
| 266 | AVIR | Atea Pharmaceuticals, Inc. | 312.47M | -6.06% | 372,411 | - |
| 267 | VNDA | Vanda Pharmaceuticals Inc. | 308.45M | 3.31% | 635,346 | 177.60M |
| 268 | XOMA | XOMA Corporation | 305.64M | 2.74% | 1,367 | 5.81M |
| 269 | VTYX | Ventyx Biosciences, Inc. | 302.44M | 2.88% | 170,295 | - |
| 270 | ATNM | Actinium Pharmaceuticals, Inc. | 298.43M | 1.33% | 226,903 | 81.00K |
| 271 | MGNX | MacroGenics, Inc. | 296.46M | 6.52% | 2,247,491 | 43.36M |
| 272 | XERS | Xeris Biopharma Holdings, Inc. | 295.80M | 5.00% | 1,456,738 | 171.36M |
| 273 | IVVD | Invivyd, Inc. | 293.28M | 0.62% | 281,483 | - |
| 274 | CRMD | CorMedix Inc. | 291.83M | -0.19% | 322,733 | - |
| 275 | INZY | Inozyme Pharma, Inc. | 290.72M | 1.40% | 206,496 | - |
| 276 | ADAP | Adaptimmune Therapeutics plc | 283.94M | 6.09% | 1,228,738 | 60.28M |
| 277 | ENTA | Enanta Pharmaceuticals, Inc. | 283.59M | 1.13% | 21,150 | 72.88M |
| 278 | OPT | Opthea Limited | 280.52M | -1.93% | 17,407 | 385.28K |
| 279 | RANI | Rani Therapeutics Holdings, Inc. | 279.04M | -4.24% | 84,593 | - |
| 280 | CDXC | ChromaDex Corporation | 277.98M | 0.55% | 106,199 | 83.17M |
| 281 | EPIX | ESSA Pharma Inc. | 274.25M | 3.83% | 36,770 | - |
| 282 | CYBN | Cybin Inc. | 272.24M | 0.94% | 1,849,725 | - |
| 283 | GLUE | Monte Rosa Therapeutics, Inc. | 268.47M | 6.40% | 49,433 | 1.06M |
| 284 | XBIT | XBiotech Inc. | 265.26M | -0.34% | 27,050 | - |
| 285 | ACRV | Acrivon Therapeutics, Inc. | 264.85M | 2.75% | 17,413 | - |
| 286 | QSI | Quantum-Si incorporated | 262.52M | 1.64% | 223,525 | 1.29M |
| 287 | CDXS | Codexis, Inc. | 262.47M | 1.92% | 275,255 | 74.23M |
| 288 | IPSC | Century Therapeutics, Inc. | 260.14M | -0.16% | 38,597 | 1.37M |
| 289 | DSGN | Design Therapeutics, Inc. | 257.05M | 0.89% | 79,903 | - |
| 290 | GBIO | Generation Bio Co. | 255.32M | 9.18% | 215,900 | 9.96M |
| 291 | TSVT | 2seventy bio, Inc. | 252.91M | 4.33% | 182,791 | 71.20M |
| 292 | CHRS | Coherus BioSciences, Inc. | 250.68M | 5.05% | 1,652,202 | 301.87M |
| 293 | PYXS | Pyxis Oncology, Inc. | 249.05M | 1.19% | 244,096 | 16.15M |
| 294 | ALDX | Aldeyra Therapeutics, Inc. | 247.76M | 0.24% | 275,266 | - |
| 295 | GTHX | G1 Therapeutics, Inc. | 246.77M | 1.51% | 280,054 | 84.04M |
| 296 | MGX | Metagenomi, Inc. | 246.57M | 0.92% | 34,063 | 47.26M |
| 297 | QURE | uniQure N.V. | 245.12M | 2.75% | 335,893 | 19.00M |
| 298 | AKBA | Akebia Therapeutics, Inc. | 241.03M | -6.10% | 2,953,319 | 187.23M |
| 299 | OMER | Omeros Corporation | 239.31M | -1.79% | 287,233 | - |
| 300 | OVID | Ovid Therapeutics Inc. | 238.63M | 4.49% | 105,771 | 473.54K |
| 301 | FHTX | Foghorn Therapeutics Inc. | 231.24M | -3.17% | 39,103 | 33.90M |
| 302 | AGEN | Agenus Inc. | 230.26M | 2.80% | 224,877 | 161.42M |
| 303 | PBYI | Puma Biotechnology, Inc. | 229.38M | -3.74% | 203,559 | 226.63M |
| 304 | ABOS | Acumen Pharmaceuticals, Inc. | 227.40M | 2.85% | 155,832 | - |
| 305 | ZURA | Zura Bio Limited | 222.98M | -0.10% | 90,506 | - |
| 306 | ELYM | Eliem Therapeutics, Inc. | 221.65M | -1.95% | 77,315 | - |
| 307 | CMPX | Compass Therapeutics, Inc. | 220.07M | -1.24% | 543,175 | - |
| 308 | MACK | Merrimack Pharmaceuticals, Inc. | 219.94M | 0.10% | 233,723 | - |
| 309 | INMB | INmune Bio, Inc. | 217.37M | 4.29% | 72,213 | 131.00K |
| 310 | CLLS | Cellectis S.A. | 217.05M | -0.49% | 8,892 | 9.19M |
| 311 | PRLD | Prelude Therapeutics Incorporated | 217.02M | 2.85% | 31,463 | - |
| 312 | HOWL | Werewolf Therapeutics, Inc. | 216.84M | 1.12% | 64,307 | 16.22M |
| 313 | IPHA | Innate Pharma S.A. | 214.23M | 0.20% | 7,492 | 68.49M |
| 314 | ANL | Adlai Nortye Ltd. | 214.07M | 4.13% | 4,267 | 5.00M |
| 315 | VERU | Veru Inc. | 213.93M | -0.34% | 919,879 | 13.48M |
| 316 | CDT | Conduit Pharmaceuticals Inc. | 212.26M | 0.35% | 5,074 | - |
| 317 | BOLD | Boundless Bio, Inc. | 210.39M | 1.56% | 58,879 | - |
| 318 | LCTX | Lineage Cell Therapeutics, Inc. | 208.62M | 6.25% | 736,751 | 8.00M |
| 319 | BLUE | bluebird bio, Inc. | 208.16M | 0.93% | 2,441,228 | 21.73M |
| 320 | ATOS | Atossa Therapeutics, Inc. | 206.75M | 6.82% | 926,209 | - |
| 321 | ELEV | Elevation Oncology, Inc. | 204.62M | 5.06% | 182,723 | - |
| 322 | ZVRA | Zevra Therapeutics, Inc. | 204.25M | 1.77% | 109,636 | 28.01M |
| 323 | CRVO | CervoMed Inc. | 202.26M | -1.17% | 14,099 | 6.36M |
| 324 | TELO | Telomir Pharmaceuticals, Inc. | 200.80M | -0.47% | 4,220 | - |
| 325 | KOD | Kodiak Sciences Inc. | 199.59M | -1.04% | 267,872 | - |
| 326 | CGEN | Compugen Ltd. | 195.18M | 4.55% | 234,039 | 33.46M |
| 327 | IVA | Inventiva S.A. | 194.82M | 1.92% | 10,613 | 25.74M |
| 328 | TRVI | Trevi Therapeutics, Inc. | 194.75M | -5.82% | 166,917 | - |
| 329 | GALT | Galectin Therapeutics Inc. | 191.90M | 9.15% | 92,669 | - |
| 330 | YS | YS Biopharma Co., Ltd. | 189.27M | 1.71% | 52,951 | - |
| 331 | GNFT | Genfit S.A. | 188.31M | 2.71% | 1,527 | 42.42M |
| 332 | GLSI | Greenwich LifeSciences, Inc. | 188.27M | 7.44% | 16,462 | - |
| 333 | FENC | Fennec Pharmaceuticals Inc. | 185.09M | -5.45% | 591,615 | 44.95M |
| 334 | ABEO | Abeona Therapeutics Inc. | 184.92M | 10.95% | 758,317 | 3.50M |
| 335 | DRTS | Alpha Tau Medical Ltd. | 184.63M | -0.56% | 12,824 | - |
| 336 | ADVM | Adverum Biotechnologies, Inc. | 182.25M | -1.79% | 127,070 | - |
| 337 | ACHV | Achieve Life Sciences, Inc. | 180.90M | 5.49% | 160,302 | - |
| 338 | OBIO | Orchestra BioMed Holdings, Inc. | 177.32M | -5.38% | 14,643 | 2.22M |
| 339 | OTLK | Outlook Therapeutics, Inc. | 172.64M | 0.74% | 139,906 | - |
| 340 | MDWD | MediWound Ltd. | 168.86M | -0.28% | 44,796 | 18.69M |
| 341 | RIGL | Rigel Pharmaceuticals, Inc. | 168.44M | 1.35% | 202,966 | 120.35M |
| 342 | SCPH | scPharmaceuticals Inc. | 168.37M | 3.78% | 579,609 | 17.63M |
| 343 | GOSS | Gossamer Bio, Inc. | 167.09M | 0.42% | 1,376,133 | - |
| 344 | CAPR | Capricor Therapeutics, Inc. | 166.65M | 1.73% | 152,473 | 27.10M |
| 345 | XFOR | X4 Pharmaceuticals, Inc. | 163.76M | -2.39% | 840,447 | - |
| 346 | VXRT | Vaxart, Inc. | 162.99M | 6.64% | 1,532,442 | 8.89M |
| 347 | TVGN | Tevogen Bio Holdings Inc. | 161.32M | 2.26% | 454,328 | - |
| 348 | CRDF | Cardiff Oncology, Inc. | 159.89M | -0.14% | 244,409 | 610.00K |
| 349 | RENB | Renovaro Biosciences Inc. | 159.43M | -4.81% | 161,047 | - |
| 350 | PRQR | ProQR Therapeutics N.V. | 156.32M | -3.53% | 80,236 | 14.66M |
| 351 | CTMX | CytomX Therapeutics, Inc. | 153.51M | 1.80% | 2,680,314 | 119.18M |
| 352 | SYRS | Syros Pharmaceuticals, Inc. | 151.82M | 3.96% | 122,878 | 6.98M |
| 353 | RPTX | Repare Therapeutics Inc. | 151.11M | -4.20% | 121,344 | 97.86M |
| 354 | SGMT | Sagimet Biosciences Inc. | 148.08M | 5.48% | 278,633 | 2.00M |
| 355 | RAPT | RAPT Therapeutics, Inc. | 143.80M | 3.13% | 581,492 | - |
| 356 | MCRB | Seres Therapeutics, Inc. | 143.10M | 5.47% | 2,951,698 | 126.85M |
| 357 | IMAB | I-Mab | 142.55M | - | 112,495 | 3.90M |
| 358 | BCAB | BioAtla, Inc. | 141.91M | 13.22% | 945,084 | - |
| 359 | SEER | Seer, Inc. | 137.02M | -1.85% | 169,716 | 15.67M |
| 360 | CRVS | Corvus Pharmaceuticals, Inc. | 135.74M | -4.87% | 181,187 | - |
| 361 | KPTI | Karyopharm Therapeutics Inc. | 132.42M | 3.21% | 988,091 | 140.46M |
| 362 | PDSB | PDS Biotechnology Corporation | 131.13M | 1.27% | 333,017 | - |
| 363 | RGLS | Regulus Therapeutics Inc. | 130.93M | -3.85% | 392,838 | - |
| 364 | DBVT | DBV Technologies S.A. | 130.91M | 2.25% | 92,258 | 14.94M |
| 365 | LIFE | aTyr Pharma, Inc. | 130.09M | 3.85% | 410,637 | 588.00K |
| 366 | AMLX | Amylyx Pharmaceuticals, Inc. | 127.85M | - | 585,671 | 398.00M |
| 367 | CNTX | Context Therapeutics Inc. | 127.50M | -0.58% | 206,077 | - |
| 368 | OMGA | Omega Therapeutics, Inc. | 126.19M | -3.39% | 357,874 | 4.94M |
| 369 | VIGL | Vigil Neuroscience, Inc. | 125.53M | -7.90% | 22,522 | - |
| 370 | VTGN | VistaGen Therapeutics, Inc. | 124.32M | 1.86% | 77,185 | 1.04M |
| 371 | MOLN | Molecular Partners AG | 123.11M | -1.12% | 1,611 | 8.38M |
| 372 | SGMO | Sangamo Therapeutics, Inc. | 122.19M | 4.28% | 1,205,842 | 18.76M |
| 373 | COYA | Coya Therapeutics, Inc. | 120.89M | -0.61% | 13,860 | 6.13M |
| 374 | CLRB | Cellectar Biosciences, Inc. | 120.81M | 6.60% | 803,764 | - |
| 375 | NVCT | Nuvectis Pharma, Inc. | 118.86M | -3.69% | 94,661 | - |
| 376 | FGEN | FibroGen, Inc. | 117.88M | 0.42% | 1,231,950 | 167.49M |
| 377 | DMAC | DiaMedica Therapeutics Inc. | 117.69M | 2.98% | 10,299 | - |
| 378 | ACET | Adicet Bio, Inc. | 117.50M | 7.52% | 911,466 | - |
| 379 | IMUX | Immunic, Inc. | 117.10M | 1.56% | 93,867 | - |
| 380 | CTXR | Citius Pharmaceuticals, Inc. | 115.97M | -6.75% | 1,177,585 | - |
| 381 | VOR | Vor Biopharma Inc. | 115.28M | 0.89% | 81,921 | - |
| 382 | ADAG | Adagene Inc. | 115.18M | -1.84% | 12,574 | 18.11M |
| 383 | PMVP | PMV Pharmaceuticals, Inc. | 109.83M | 0.23% | 194,966 | - |
| 384 | BYSI | BeyondSpring Inc. | 108.27M | 4.49% | 50,104 | 1.75M |
| 385 | RZLT | Rezolute, Inc. | 106.74M | 0.37% | 85,791 | - |
| 386 | LPTX | Leap Therapeutics, Inc. | 106.38M | 1.09% | 226,820 | - |
| 387 | ELTX | Elicio Therapeutics, Inc. | 105.90M | -0.58% | 30,594 | - |
| 388 | ALLK | Allakos Inc. | 104.93M | -0.42% | 106,397 | - |
| 389 | RLMD | Relmada Therapeutics, Inc. | 104.40M | -4.67% | 53,838 | - |
| 390 | VANI | Vivani Medical, Inc. | 102.81M | 2.13% | 152,133 | - |
| 391 | CNTB | Connect Biopharma Holdings Limited | 101.03M | -5.52% | 114,831 | - |
| 392 | ANVS | Annovis Bio, Inc. | 99.31M | 6.58% | 863,371 | - |
| 393 | CLSD | Clearside Biomedical, Inc. | 97.90M | 2.34% | 127,239 | 8.45M |
| 394 | GNLX | Genelux Corporation | 96.72M | 0.56% | 48,098 | 8.00K |
| 395 | ORMP | Oramed Pharmaceuticals Inc. | 96.49M | -3.60% | 101,281 | 674.00K |
| 396 | ARMP | Armata Pharmaceuticals, Inc. | 95.81M | -5.82% | 22,109 | 4.70M |
| 397 | ENTX | Entera Bio Ltd. | 94.38M | 4.98% | 156,114 | - |
| 398 | ANIX | Anixa Biosciences, Inc. | 93.31M | -0.17% | 28,020 | 210.00K |
| 399 | IOBT | IO Biotech, Inc. | 92.23M | -2.78% | 81,925 | - |
| 400 | MIST | Milestone Pharmaceuticals Inc. | 91.42M | - | 38,315 | - |
| 401 | BRNS | Barinthus Biotherapeutics plc | 89.59M | -1.29% | 6,600 | 334.00K |
| 402 | CMRX | Chimerix, Inc. | 88.04M | -1.39% | 71,360 | 41.00K |
| 403 | ONCY | Oncolytics Biotech Inc. | 87.86M | -0.85% | 236,204 | - |
| 404 | ALVR | AlloVir, Inc. | 87.37M | -2.86% | 84,714 | - |
| 405 | SPRO | Spero Therapeutics, Inc. | 87.31M | 1.19% | 109,866 | 103.78M |
| 406 | ATHA | Athira Pharma, Inc. | 85.09M | 0.91% | 110,176 | - |
| 407 | PLX | Protalix BioTherapeutics, Inc. | 84.31M | -1.29% | 160,711 | 59.65M |
| 408 | DTIL | Precision BioSciences, Inc. | 84.21M | 4.78% | 66,980 | 57.53M |
| 409 | IFRX | InflaRx N.V. | 82.44M | -3.50% | 64,599 | 107.75K |
| 410 | GRTS | Gritstone bio, Inc. | 82.27M | -0.33% | 1,055,992 | 15.65M |
| 411 | SLS | SELLAS Life Sciences Group, Inc. | 82.01M | 4.38% | 1,034,465 | - |
| 412 | AFMD | Affimed N.V. | 81.84M | 2.54% | 18,452 | 9.19M |
| 413 | HOOK | HOOKIPA Pharma Inc. | 81.59M | 3.03% | 296,059 | 53.55M |
| 414 | BNTC | Benitec Biopharma Inc. | 81.40M | 3.08% | 5,688 | 7.00K |
| 415 | TIL | Instil Bio, Inc. | 80.79M | 4.55% | 4,990 | - |
| 416 | BTAI | BioXcel Therapeutics, Inc. | 79.94M | -0.47% | 464,816 | 1.76M |
| 417 | ASMB | Assembly Biosciences, Inc. | 78.62M | 1.49% | 6,836 | - |
| 418 | PALI | Palisade Bio, Inc. | 78.37M | -2.24% | 23,565 | - |
| 419 | CGTX | Cognition Therapeutics, Inc. | 78.12M | -0.51% | 123,887 | - |
| 420 | LVTX | LAVA Therapeutics N.V. | 77.82M | 2.42% | 22,353 | 7.52M |
| 421 | PASG | Passage Bio, Inc. | 77.78M | -4.15% | 56,105 | - |
| 422 | CUE | Cue Biopharma, Inc. | 77.34M | 3.23% | 145,357 | 7.02M |
| 423 | ATRA | Atara Biotherapeutics, Inc. | 77.07M | 7.02% | 508,226 | 34.70M |
| 424 | CELU | Celularity Inc. | 76.24M | -4.40% | 27,134 | 14.79M |
| 425 | TPST | Tempest Therapeutics, Inc. | 75.76M | 0.29% | 267,830 | - |
| 426 | CVM | CEL-SCI Corporation | 75.57M | 0.72% | 232,167 | - |
| 427 | MRNS | Marinus Pharmaceuticals, Inc. | 75.53M | 2.61% | 663,030 | 28.29M |
| 428 | CRIS | Curis, Inc. | 75.15M | -19.06% | 60,723 | 9.81M |
| 429 | SER | Serina Therapeutics Inc | 74.36M | -2.65% | 19,826 | 3.15M |
| 430 | JAGX | Jaguar Health, Inc. | 73.90M | -7.28% | 20,182,877 | 10.14M |
| 431 | CLGN | CollPlant Biotechnologies Ltd. | 72.97M | -4.43% | 3,770 | 10.96M |
| 432 | RLYB | Rallybio Corporation | 72.22M | 3.26% | 156,061 | - |
| 433 | MNOV | MediciNova, Inc. | 71.62M | -1.35% | 1,519 | 1.00M |
| 434 | TARA | Protara Therapeutics, Inc. | 70.83M | 1.50% | 905,171 | - |
| 435 | LABP | Landos Biopharma, Inc. | 70.18M | - | 2,461 | - |
| 436 | TSBX | Turnstone Biologics Corp. | 68.25M | -1.74% | 31,024 | 19.31M |
| 437 | LTRN | Lantern Pharma Inc. | 67.24M | 1.29% | 69,390 | - |
| 438 | ANTX | AN2 Therapeutics, Inc. | 65.92M | -4.33% | 185,502 | - |
| 439 | ALRN | Aileron Therapeutics, Inc. | 65.79M | - | 11,891 | - |
| 440 | MURA | Mural Oncology plc | 65.49M | -1.28% | 76,736 | - |
| 441 | CSBR | Champions Oncology, Inc. | 65.43M | 3.51% | 60,766 | 49.22M |
| 442 | INTS | Intensity Therapeutics, Inc. | 65.41M | 7.92% | 37,988 | - |
| 443 | ANEB | Anebulo Pharmaceuticals, Inc. | 64.70M | 6.17% | 7,698 | - |
| 444 | IKNA | Ikena Oncology, Inc. | 64.18M | 0.75% | 89,213 | 3.85M |
| 445 | AEON | AEON Biopharma, Inc. | 63.22M | -1.60% | 80,917 | - |
| 446 | IMMX | Immix Biopharma, Inc. | 62.71M | 7.95% | 85,967 | - |
| 447 | VTVT | vTv Therapeutics Inc. | 62.03M | -1.87% | 1,034 | 1.00M |
| 448 | AVRO | AVROBIO, Inc. | 60.83M | 4.65% | 446,583 | - |
| 449 | THTX | Theratechnologies Inc. | 60.69M | 6.50% | 13,362 | 57.85M |
| 450 | ELDN | Eledon Pharmaceuticals, Inc. | 60.66M | 6.41% | 114,107 | - |
| 451 | TLSA | Tiziana Life Sciences Ltd | 60.34M | 8.23% | 156,317 | - |
| 452 | OCEA | Ocean Biomedical, Inc. | 59.94M | 10.90% | 697,299 | - |
| 453 | KRON | Kronos Bio, Inc. | 59.49M | -0.95% | 113,819 | 7.59M |
| 454 | CKPT | Checkpoint Therapeutics, Inc. | 59.33M | 2.56% | 186,677 | 68.00K |
| 455 | CARM | Carisma Therapeutics, Inc. | 59.20M | -2.05% | 99,450 | 15.07M |
| 456 | GNTA | Genenta Science S.p.A. | 58.30M | -0.62% | 3,052 | - |
| 457 | CDTX | Cidara Therapeutics, Inc. | 57.89M | -0.31% | 13,789 | 63.91M |
| 458 | KZR | Kezar Life Sciences, Inc. | 56.96M | -0.94% | 238,299 | 7.00M |
| 459 | RPHM | Reneo Pharmaceuticals, Inc. | 54.31M | 0.31% | 299,441 | - |
| 460 | EQ | Equillium, Inc. | 54.29M | 4.35% | 41,773 | 37.89M |
| 461 | ABIO | ARCA biopharma, Inc. | 53.68M | 11.75% | 128,676 | - |
| 462 | BLRX | BioLineRx Ltd. | 52.45M | -3.63% | 352,917 | 4.80M |
| 463 | EYEN | Eyenovia, Inc. | 52.23M | 24.65% | 1,811,732 | 3.79K |
| 464 | NTRB | Nutriband Inc. | 51.45M | 22.31% | 132,267 | 2.09M |
| 465 | ALGS | Aligos Therapeutics, Inc. | 51.06M | -1.39% | 55,851 | 13.79M |
| 466 | INAB | IN8bio, Inc. | 49.20M | 5.77% | 757,330 | - |
| 467 | CLNN | Clene Inc. | 48.83M | -0.65% | 124,841 | 620.00K |
| 468 | OKYO | OKYO Pharma Limited | 47.86M | -2.03% | 9,464 | - |
| 469 | MLEC | Moolec Science SA | 47.33M | - | 83,221 | 2.90M |
| 470 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 46.76M | -8.22% | 334,055 | - |
| 471 | IMRX | Immuneering Corporation | 46.70M | -1.25% | 58,342 | - |
| 472 | DYAI | Dyadic International, Inc. | 46.24M | 8.05% | 99,506 | 2.26M |
| 473 | AADI | Aadi Bioscience, Inc. | 45.67M | -1.06% | 58,214 | 23.84M |
| 474 | GANX | Gain Therapeutics, Inc. | 45.50M | 8.97% | 116,432 | - |
| 475 | CASI | CASI Pharmaceuticals, Inc. | 45.43M | 7.64% | 53,944 | 33.88M |
| 476 | NXTC | NextCure, Inc. | 45.04M | 2.52% | 8,316 | - |
| 477 | OCUP | Ocuphire Pharma, Inc. | 44.31M | 2.35% | 89,101 | 19.01M |
| 478 | MTNB | Matinas BioPharma Holdings, Inc. | 43.84M | -0.46% | 849,950 | - |
| 479 | CTCX | Carmell Therapeutics Corporation | 43.81M | -1.43% | 6,429 | - |
| 480 | HCWB | HCW Biologics Inc. | 43.50M | - | 21,467 | 560.36K |
| 481 | XLO | Xilio Therapeutics, Inc. | 41.72M | 5.50% | 92,815 | - |
| 482 | CARA | Cara Therapeutics, Inc. | 41.48M | 4.80% | 378,970 | 16.94M |
| 483 | UNCY | Unicycive Therapeutics, Inc. | 40.62M | -0.92% | 53,651 | - |
| 484 | VYNE | VYNE Therapeutics Inc. | 40.01M | -1.80% | 23,021 | 423.00K |
| 485 | MAIA | MAIA Biotechnology, Inc. | 39.86M | 2.46% | 51,623 | - |
| 486 | LEXX | Lexaria Bioscience Corp. | 39.30M | - | 103,518 | 386.00K |
| 487 | QNCX | Quince Therapeutics, Inc. | 38.91M | -0.15% | 61,802 | - |
| 488 | IGC | IGC Pharma Inc | 38.19M | 3.72% | 192,399 | 1.22M |
| 489 | ESLA | Estrella Immunopharma, Inc. | 38.13M | -2.62% | 3,672 | - |
| 490 | SNSE | Sensei Biotherapeutics, Inc. | 38.00M | -0.66% | 72,266 | - |
| 491 | ACHL | Achilles Therapeutics plc | 37.82M | 0.04% | 11,198 | - |
| 492 | ICCC | ImmuCell Corporation | 37.17M | -12.73% | 59,811 | 21.28M |
| 493 | MRKR | Marker Therapeutics, Inc. | 36.99M | 1.37% | 13,435 | 3.31M |
| 494 | SABS | SAB Biotherapeutics, Inc. | 36.91M | -3.61% | 1,360 | 2.24M |
| 495 | DARE | Daré Bioscience, Inc. | 36.20M | 14.13% | 1,482,447 | 2.82M |
| 496 | ACXP | Acurx Pharmaceuticals, Inc. | 35.76M | 7.89% | 139,372 | - |
| 497 | INKT | MiNK Therapeutics, Inc. | 35.75M | -8.93% | 209,596 | - |
| 498 | EVGN | Evogene Ltd. | 35.16M | -0.71% | 58,503 | 5.64M |
| 499 | PMN | ProMIS Neurosciences, Inc. | 34.70M | -3.21% | 3,411 | - |
| 500 | FBIO | Fortress Biotech, Inc. | 34.05M | 0.57% | 53,630 | 84.51M |
| 501 | SRZN | Surrozen, Inc. | 33.59M | -0.68% | 41,307 | - |
| 502 | RNXT | RenovoRx, Inc. | 33.53M | -2.78% | 8,766 | - |
| 503 | NRXP | NRx Pharmaceuticals, Inc. | 33.46M | 0.63% | 148,221 | - |
| 504 | PLUR | Pluri Inc. | 33.36M | -5.06% | 5,715 | 341.00K |
| 505 | PTN | Palatin Technologies, Inc. | 33.08M | -14.73% | 341,171 | 7.10M |
| 506 | BOLT | Bolt Biotherapeutics, Inc. | 33.01M | -34.38% | 2,940,443 | 11.32M |
| 507 | BCLI | Brainstorm Cell Therapeutics Inc. | 32.67M | -4.00% | 288,443 | - |
| 508 | SPRB | Spruce Biosciences, Inc. | 32.51M | -4.79% | 577,652 | 10.13M |
| 509 | VIRX | Viracta Therapeutics, Inc. | 32.21M | 2.00% | 51,596 | - |
| 510 | APLM | Apollomics, Inc. | 30.77M | 1.12% | 72,635 | - |
| 511 | APRE | Aprea Therapeutics, Inc. | 30.19M | -5.76% | 8,291 | 963.80K |
| 512 | IPA | ImmunoPrecise Antibodies Ltd. | 28.95M | -3.81% | 68,826 | 17.67M |
| 513 | LPCN | Lipocine Inc. | 28.89M | 4.67% | 24,948 | 4.71M |
| 514 | BCTX | BriaCell Therapeutics Corp. | 27.97M | -18.01% | 189,168 | - |
| 515 | ICU | SeaStar Medical Holding Corporation | 27.57M | -5.65% | 755,646 | - |
| 516 | BIVI | BioVie Inc. | 27.34M | -0.30% | 307,645 | - |
| 517 | ENLV | Enlivex Therapeutics Ltd. | 26.40M | -2.62% | 59,053 | - |
| 518 | BIOR | Biora Therapeutics, Inc. | 26.18M | -1.06% | 185,991 | 4.00K |
| 519 | GDTC | CytoMed Therapeutics Limited | 26.02M | 8.94% | 621 | - |
| 520 | UBX | Unity Biotechnology, Inc. | 25.74M | 0.65% | 33,572 | - |
| 521 | NKGN | NKGen Biotech, Inc. | 25.64M | -0.88% | 39,255 | - |
| 522 | ACST | Acasti Pharma Inc. | 25.10M | -3.96% | 15,497 | - |
| 523 | ITRM | Iterum Therapeutics plc | 25.09M | 1.00% | 47,877 | - |
| 524 | ONCT | Oncternal Therapeutics, Inc. | 24.97M | -0.47% | 946 | 1.15M |
| 525 | APM | Aptorum Group Limited | 24.09M | 2.39% | 8,091 | 431.38K |
| 526 | FBRX | Forte Biosciences, Inc. | 24.05M | -2.96% | 22,297 | - |
| 527 | LSTA | Lisata Therapeutics, Inc. | 22.44M | - | 3,399 | - |
| 528 | LYRA | Lyra Therapeutics, Inc. | 22.27M | -1.75% | 1,724,972 | 1.68M |
| 529 | NNVC | NanoViricides, Inc. | 21.79M | -17.26% | 269,454 | - |
| 530 | MEIP | MEI Pharma, Inc. | 21.12M | 0.32% | 4,523 | 66.75M |
| 531 | COCP | Cocrystal Pharma, Inc. | 20.99M | 8.99% | 49,138 | - |
| 532 | SYBX | Synlogic, Inc. | 20.58M | 1.14% | 127,720 | 3.21M |
| 533 | NRSN | NeuroSense Therapeutics Ltd. | 20.41M | 5.18% | 45,814 | - |
| 534 | NRBO | NeuroBo Pharmaceuticals, Inc. | 20.36M | 0.97% | 9,644 | - |
| 535 | AIM | AIM ImmunoTech Inc. | 20.35M | 4.14% | 134,446 | 202.00K |
| 536 | VINC | Vincerx Pharma, Inc. | 20.29M | -2.17% | 246,439 | - |
| 537 | ORGS | Orgenesis Inc. | 20.28M | -2.43% | 4,612 | 530.00K |
| 538 | EVAX | Evaxion Biotech A/S | 20.18M | 0.53% | 11,114 | 73.00K |
| 539 | APTO | Aptose Biosciences Inc. | 19.83M | -0.81% | 20,261 | - |
| 540 | TCRT | Alaunos Therapeutics, Inc. | 19.38M | -7.39% | 17,201 | 5.00K |
| 541 | PHGE | BiomX Inc. | 19.08M | -0.12% | 40,692 | - |
| 542 | VBIV | VBI Vaccines Inc. | 18.94M | 2.94% | 141,477 | 8.68M |
| 543 | KALA | Kala Pharmaceuticals, Inc. | 18.81M | -4.30% | 1,699 | - |
| 544 | LUMO | Lumos Pharma, Inc. | 18.70M | -10.08% | 123,673 | 2.05M |
| 545 | CDIO | Cardio Diagnostics Holdings, Inc. | 18.49M | 9.39% | 400,168 | 17.07K |
| 546 | SLGL | Sol-Gel Technologies Ltd. | 18.39M | 4.90% | 27,047 | 1.55M |
| 547 | INDP | Indaptus Therapeutics, Inc. | 18.19M | 13.49% | 25,250 | - |
| 548 | ATHE | Alterity Therapeutics Limited | 18.10M | -0.72% | 3,951 | - |
| 549 | PMCB | PharmaCyte Biotech, Inc. | 18.09M | -1.39% | 806 | - |
| 550 | GLYC | GlycoMimetics, Inc. | 17.94M | 0.80% | 822,828 | 10.00K |
| 551 | NRXS | NeurAxis, Inc. | 17.81M | -2.48% | 6,048 | 2.46M |
| 552 | NERV | Minerva Neurosciences, Inc. | 17.66M | 2.82% | 7,848 | - |
| 553 | GLTO | Galecto, Inc. | 17.08M | -7.38% | 293,730 | - |
| 554 | TRAW | Traws Pharma, Inc. | 16.45M | 1.29% | 23,307 | 226.00K |
| 555 | SNTI | Senti Biosciences, Inc. | 16.21M | -4.26% | 54,074 | 1.28M |
| 556 | IBIO | iBio, Inc. | 16.19M | 0.80% | 60,538 | 50.00K |
| 557 | TNXP | Tonix Pharmaceuticals Holding Corp. | 15.47M | 1.78% | 820,043 | 10.25M |
| 558 | XTLB | XTL Biopharmaceuticals Ltd. | 15.25M | -0.37% | 10,248 | - |
| 559 | EDSA | Edesa Biotech, Inc. | 14.85M | -0.44% | 32,846 | - |
| 560 | ADXN | Addex Therapeutics Ltd | 14.09M | -3.91% | 9,802 | 1.96M |
| 561 | PIRS | Pieris Pharmaceuticals, Inc. | 14.01M | 1.80% | 6,088 | 42.81M |
| 562 | PPBT | Purple Biotech Ltd. | 13.65M | 2.62% | 39,981 | - |
| 563 | ONVO | Organovo Holdings, Inc. | 13.64M | 6.97% | 335,713 | 242.00K |
| 564 | IMNN | Imunon, Inc. | 13.54M | 10.78% | 14,902 | - |
| 565 | KPRX | Kiora Pharmaceuticals, Inc. | 13.30M | 1.26% | 32,468 | 16.00M |
| 566 | IMRN | Immuron Limited | 12.88M | -0.86% | 4,359 | 2.43M |
| 567 | COEP | Coeptis Therapeutics, Inc. | 12.64M | 1.41% | 50,505 | - |
| 568 | CHRO | Chromocell Therapeutics Corp | 12.46M | -2.30% | 21,320 | - |
| 569 | IKT | Inhibikase Therapeutics, Inc. | 12.46M | 26.32% | 513,606 | 260.50K |
| 570 | DOMH | Dominari Holdings Inc. | 12.17M | 5.85% | 1,537 | 3.41M |
| 571 | CMMB | Chemomab Therapeutics Ltd. | 12.09M | -2.41% | 35,745 | - |
| 572 | ABVC | ABVC BioPharma, Inc. | 11.51M | 1.85% | 294,673 | 152.43K |
| 573 | CANF | Can-Fite BioPharma Ltd. | 11.28M | 2.35% | 2,375 | 743.00K |
| 574 | CLDI | Calidi Biotherapeutics, Inc. | 11.26M | -0.62% | 106,736 | - |
| 575 | MNPR | Monopar Therapeutics Inc. | 11.21M | -2.53% | 25,252 | - |
| 576 | MBRX | Moleculin Biotech, Inc. | 11.14M | - | 7,886 | - |
| 577 | ELAB | Elevai Labs, Inc. | 11.06M | -1.39% | 23,965 | 1.71M |
| 578 | AVTX | Avalo Therapeutics, Inc. | 10.99M | 0.27% | 26,465 | 1.45M |
| 579 | ERNA | Eterna Therapeutics Inc. | 10.98M | -11.76% | 22,690 | 115.00K |
| 580 | BCDA | BioCardia, Inc. | 10.57M | -0.68% | 84,591 | 468.00K |
| 581 | AEZS | Aeterna Zentaris Inc. | 10.32M | 2.14% | 13,699 | 4.50M |
| 582 | FRES | Fresh2 Group Ltd | 10.23M | 3.90% | 4,163 | 2.35M |
| 583 | MTEM | Molecular Templates, Inc. | 10.03M | 2.01% | 42,908 | 57.31M |
| 584 | BNOX | Bionomics Limited | 9.99M | -4.15% | 36,013 | 15.00K |
| 585 | GRTX | Galera Therapeutics, Inc. | 9.86M | 2.23% | 183,166 | - |
| 586 | NTBL | Notable Labs, Ltd. | 9.74M | -1.73% | 53,668 | 310.00K |
| 587 | AKTX | Akari Therapeutics, Plc | 9.63M | 2.74% | 2,080 | - |
| 588 | PSTV | Plus Therapeutics, Inc. | 9.62M | 5.67% | 151,742 | 4.91M |
| 589 | BRTX | BioRestorative Therapies, Inc. | 9.27M | 0.66% | 106,749 | 145.80K |
| 590 | EFTR | eFFECTOR Therapeutics, Inc. | 9.27M | -0.50% | 96,694 | - |
| 591 | LGVN | Longeveron Inc. | 8.54M | -0.72% | 423,325 | 978.00K |
| 592 | NCNA | NuCana plc | 8.26M | 0.53% | 19,420 | - |
| 593 | VCNX | Vaccinex, Inc. | 7.99M | -1.23% | 3,367 | 570.00K |
| 594 | CYCN | Cyclerion Therapeutics, Inc. | 7.81M | -2.37% | 156 | - |
| 595 | TRVN | Trevena, Inc. | 7.67M | 0.96% | 24,416 | 3.13M |
| 596 | VIRI | Virios Therapeutics, Inc. | 7.44M | 2.52% | 44,500 | - |
| 597 | OGEN | Oragenics, Inc. | 7.34M | -1.82% | 61,274 | 37.65K |
| 598 | PYPD | PolyPid Ltd. | 7.20M | -7.28% | 161 | - |
| 599 | KTRA | Kintara Therapeutics, Inc. | 7.12M | 1.64% | 2,989,803 | - |
| 600 | CVKD | Cadrenal Therapeutics, Inc. | 7.08M | 1.77% | 74,327 | - |
| 601 | ASLN | ASLAN Pharmaceuticals Limited | 7.06M | 0.25% | 102,277 | 12.00M |
| 602 | KTTA | Pasithea Therapeutics Corp. | 6.93M | - | 835 | - |
| 603 | TENX | Tenax Therapeutics, Inc. | 6.87M | 1.15% | 16,655 | - |
| 604 | PULM | Pulmatrix, Inc. | 6.85M | 3.89% | 9,927 | 11.68M |
| 605 | HEPA | Hepion Pharmaceuticals, Inc. | 6.73M | -6.98% | 38,537 | - |
| 606 | KZIA | Kazia Therapeutics Limited | 6.72M | -2.14% | 90,550 | 15.65K |
| 607 | TFFP | TFF Pharmaceuticals, Inc. | 6.57M | 14.36% | 24,653 | 885.72K |
| 608 | TOVX | Theriva Biologics, Inc. | 6.38M | -1.34% | 43,786 | - |
| 609 | ENVB | Enveric Biosciences, Inc. | 6.09M | -4.19% | 158,914 | - |
| 610 | KA | Kineta, Inc. | 6.01M | 1.88% | 40,687 | 5.44M |
| 611 | PTIX | Protagenic Therapeutics, Inc. | 6.00M | 3.28% | 2,731 | - |
| 612 | CELZ | Creative Medical Technology Holdings, Inc. | 5.99M | -1.38% | 856 | 9.00K |
| 613 | TTNP | Titan Pharmaceuticals, Inc. | 5.99M | -1.50% | 830 | 184.00K |
| 614 | SNGX | Soligenix, Inc. | 5.94M | -3.41% | 279,342 | 699.21K |
| 615 | XBIO | Xenetic Biosciences, Inc. | 5.85M | 0.26% | 1,089 | 2.44M |
| 616 | PCSA | Processa Pharmaceuticals, Inc. | 5.80M | -8.72% | 88,490 | - |
| 617 | LIPO | Lipella Pharmaceuticals Inc. | 5.78M | -0.34% | 11,958 | 477.45K |
| 618 | ADIL | Adial Pharmaceuticals, Inc. | 5.78M | -1.39% | 88,514 | - |
| 619 | HOTH | Hoth Therapeutics, Inc. | 5.77M | -3.31% | 24,341 | - |
| 620 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 5.66M | -0.83% | 6,271 | 92.73K |
| 621 | NLSP | NLS Pharmaceutics AG | 5.64M | -4.56% | 43,112 | - |
| 622 | FWBI | First Wave BioPharma, Inc. | 5.59M | -4.03% | 33,975 | - |
| 623 | RNAZ | TransCode Therapeutics, Inc. | 5.52M | 17.41% | 2,089,140 | - |
| 624 | GNPX | Genprex, Inc. | 5.37M | -3.40% | 23,144 | - |
| 625 | SNPX | Synaptogenix, Inc. | 5.26M | 2.13% | 37,256 | - |
| 626 | LIXT | Lixte Biotechnology Holdings, Inc. | 5.15M | -13.26% | 61,621 | - |
| 627 | SILO | Silo Pharma, Inc. | 5.15M | -3.74% | 5,262 | 72.10K |
| 628 | PRTG | Portage Biotech Inc. | 5.14M | -0.42% | 52,178 | - |
| 629 | AZTR | Azitra, Inc. | 5.07M | 0.11% | 526,874 | 572.70K |
| 630 | MYMD | MyMD Pharmaceuticals, Inc. | 4.92M | -0.65% | 8,830 | - |
| 631 | XRTX | XORTX Therapeutics Inc. | 4.91M | -2.58% | 9,715 | - |
| 632 | SEEL | Seelos Therapeutics, Inc. | 4.85M | 14.52% | 1,451,382 | 1.97M |
| 633 | NEXI | NexImmune, Inc. | 4.75M | -0.72% | 1,506 | - |
| 634 | DRUG | Bright Minds Biosciences Inc. | 4.62M | 1.90% | 23,566 | - |
| 635 | XCUR | Exicure, Inc. | 4.47M | 1.08% | 4,208 | 23.79M |
| 636 | ARTL | Artelo Biosciences, Inc. | 4.26M | -2.90% | 7,676 | - |
| 637 | ENSC | Ensysce Biosciences, Inc. | 4.26M | 6.38% | 351,955 | - |
| 638 | THAR | Tharimmune, Inc. | 4.25M | 0.93% | 196,360 | - |
| 639 | GTBP | GT Biopharma, Inc. | 4.21M | -2.24% | 8,812 | - |
| 640 | ALZN | Alzamend Neuro, Inc. | 4.19M | -1.15% | 55,113 | - |
| 641 | CMND | Clearmind Medicine Inc. | 4.15M | 1.55% | 60,108 | - |
| 642 | ADTX | Aditxt, Inc. | 4.00M | -10.45% | 16,931 | 645.18K |
| 643 | GOVX | GeoVax Labs, Inc. | 3.90M | -0.53% | 38,417 | - |
| 644 | ZVSA | ZyVersa Therapeutics, Inc. | 3.77M | -6.75% | 47,474 | - |
| 645 | TCON | TRACON Pharmaceuticals, Inc. | 3.73M | -17.53% | 173,209 | 12.15M |
| 646 | BPTH | Bio-Path Holdings, Inc. | 3.71M | -6.01% | 58,897 | - |
| 647 | TCBP | TC Biopharm (Holdings) Plc | 3.64M | -0.87% | 253,854 | - |
| 648 | NBY | NovaBay Pharmaceuticals, Inc. | 3.59M | 13.21% | 7,653,803 | 14.23M |
| 649 | PHIO | Phio Pharmaceuticals Corp. | 3.58M | 8.75% | 85,059 | - |
| 650 | MBIO | Mustang Bio, Inc. | 3.39M | 0.07% | 48,391 | - |
| 651 | CYTO | Altamira Therapeutics Ltd. | 3.34M | 1.36% | 32,348 | - |
| 652 | APVO | Aptevo Therapeutics Inc. | 3.31M | 1.45% | 106,963 | - |
| 653 | CING | Cingulate Inc. | 3.18M | -1.25% | 23,462 | - |
| 654 | FNCH | Finch Therapeutics Group, Inc. | 3.16M | 8.20% | 15,767 | - |
| 655 | CYCC | Cyclacel Pharmaceuticals, Inc. | 3.11M | -16.90% | 135,067 | 449.00K |
| 656 | REVB | Revelation Biosciences, Inc. | 3.09M | 1.61% | 11,674 | - |
| 657 | SPRC | SciSparc Ltd. | 3.01M | -3.15% | 82,146 | 2.88M |
| 658 | QNRX | Quoin Pharmaceuticals, Ltd. | 2.96M | 0.40% | 21,514 | - |
| 659 | SCPX | Scorpius Holdings, Inc. | 2.95M | 7.94% | 6,666,865 | 6.99M |
| 660 | VRPX | Virpax Pharmaceuticals, Inc. | 2.77M | -66.08% | 2,475,423 | - |
| 661 | SCNI | Scinai Immunotherapeutics Ltd. | 2.64M | - | 5,360 | - |
| 662 | ONCO | Onconetix, Inc. | 2.52M | 1.44% | 55,845 | 58.47K |
| 663 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.44M | -3.89% | 508,082 | 253.57K |
| 664 | WINT | Windtree Therapeutics, Inc. | 2.37M | 13.79% | 45,158 | - |
| 665 | GLMD | Galmed Pharmaceuticals Ltd. | 2.34M | -2.91% | 34,934 | - |
| 666 | SLRX | Salarius Pharmaceuticals, Inc. | 2.29M | - | 12,777 | - |
| 667 | ATXI | Avenue Therapeutics, Inc. | 2.25M | 1.04% | 30,477 | - |
| 668 | DRMA | Dermata Therapeutics, Inc. | 2.19M | -3.54% | 83,751 | - |
| 669 | CNSP | CNS Pharmaceuticals, Inc. | 2.18M | -1.82% | 56,785 | - |
| 670 | QLGN | Qualigen Therapeutics, Inc. | 1.97M | 3.88% | 63,212 | - |
| 671 | VRAX | Virax Biolabs Group Limited | 1.80M | 0.66% | 7,464 | 79.30K |
| 672 | ATNF | 180 Life Sciences Corp. | 1.66M | -2.50% | 6,997 | - |
| 673 | ALLR | Allarity Therapeutics, Inc. | 1.63M | -14.01% | 4,943,560 | - |
| 674 | INM | InMed Pharmaceuticals Inc. | 1.62M | 0.37% | 75,186 | 5.63M |
| 675 | GRI | GRI Bio, Inc. | 1.55M | 1.36% | 71,580 | - |
| 676 | NBSE | NeuBase Therapeutics, Inc. | 1.42M | -1.56% | 97,744 | - |
| 677 | BDRX | Biodexa Pharmaceuticals Plc | 262.53K | - | 156,205 | 482.28K |